C12N 9/002
With a cytochrome as acceptor
Official title: {with a cytochrome as acceptor (1.4.2)}
C12N9/002 (With a cytochrome as acceptor) appears on 7 US grants and 11 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 11
- Assignees
- 8
- Inventors
- 26
- Latest grant
- 19 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 1 |
| 2013 | 2 | 1 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
By publication year.
Recent patents
- Metabolically competent cells, methods of making, and uses thereof19 Mar 2024US 11,932,878 B2The Research Foundation for The State University of New York
- Biosynthesis of phenylpropanoids and phenylpropanoid derivatives1 Sep 2020US 10,760,062 B2Evolva SA
- Multimeric oxidoreductases10 Mar 2015US 8,975,048 B2Danisco US Inc.
- Multimeric oxidoreductases3 Dec 2013US 8,597,916 B2Danisco US Inc.
- Multimeric oxidoreductases8 Jan 2013US 8,349,599 B2Danisco US Inc.
- Promoters20 Jun 2024US 2024/0200095 A1Freeline Therapeutics Limited
- Programmable nucleases and base editors for modifying nucleic acid duplexes6 Jan 2022US 2022/0002717 A1
- Recombinant expression of fumonisin amine oxidase4 Nov 2021US 2021/0337838 A1Her Majesty the Queen In Right of Canada, AS Represented By the Minister of Agiculture and Agri Food
- Metabolically competent cells, methods of making, and uses thereof3 Oct 2019US 2019/0300861 A1The Research Foundation for The State University of New York
- Biosynthesis of Phenylpropanoid and Dihydrophenylpropanoid Derivatives24 May 2018US 2018/0142216 A1Evolva SA
Most cited
By later US patents